WaveMan · Form 4
Pakianathan Deepika insider trades
> Search tickers & screens ⌘K
LIVE

Pakianathan Deepika insider trades

Pakianathan Deepika has filed 22 Form 4s with the SEC that we hold, for Karyopharm Therapeutics Inc. (KPTI) (Director), Theravance Biopharma, Inc. (TBPH) (Director), Mereo BioPharma Group plc (MREO) (Director) and CALA (Director), among 5 companies in all. Across all of them we count 0 purchases worth $0 and 21 sales worth $5.6M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 322,825 shares of Karyopharm Therapeutics Inc. worth $2.1M, dated 2022-06-08. The first filing on our record is dated 2021-12-28 and the latest 2026-09-24.

Karyopharm Therapeutics Inc. (KPTI)

Director · 8 filings · 18 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-06-08S, sale reported on Form 43,152$20.5K2022-06-10
2022-06-08S, sale reported on Form 4322,825$2.1M2022-06-10
2022-06-09S, sale reported on Form 42,045$12.6K2022-06-10
2022-06-09S, sale reported on Form 4209,455$1.3M2022-06-10
2022-06-10S, sale reported on Form 413$782022-06-10
2022-06-10S, sale reported on Form 41,294$7.8K2022-06-10
2024-05-31S, sale reported on Form 4202,418$192.3K2024-06-04
2024-05-31S, sale reported on Form 41,976$1.9K2024-06-04
2024-06-03S, sale reported on Form 43,488$3.5K2024-06-04
2024-06-03S, sale reported on Form 4357,256$357.3K2024-06-04
2024-06-04S, sale reported on Form 43,298$3.1K2024-06-04
2024-06-04S, sale reported on Form 4337,742$320.9K2024-06-04
2024-06-05S, sale reported on Form 4463,518$445.0K2024-06-07
2024-06-05S, sale reported on Form 44,526$4.3K2024-06-07
2024-06-06S, sale reported on Form 41,145$1.1K2024-06-07
2024-06-06S, sale reported on Form 4117,307$115.0K2024-06-07
2024-06-07S, sale reported on Form 42,240$2.1K2024-06-07
2024-06-07S, sale reported on Form 4229,308$217.8K2024-06-07

Theravance Biopharma, Inc. (TBPH)

Director · 6 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Mereo BioPharma Group plc (MREO)

Director · 4 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2024-08-22S, sale reported on Form 4105,244$466.2K2024-08-23

CALA

Director · 2 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-01-27S, sale reported on Form 4120,161$46.9K2023-01-31
2023-01-27S, sale reported on Form 41,172$4572023-01-31

PRDS

Director · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1270734) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms